Standout Papers

Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis 1999 2026 2008 2017 959
  1. Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis (1999)
    Bonnie W. Ramsey, Margaret S. Pepe et al. New England Journal of Medicine
  2. Cystic Fibrosis Pulmonary Guidelines (2007)
    Patrick A. Flume, Brian O’Sullivan et al. American Journal of Respiratory and Critical Care Medicine
  3. Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa (2003)
    Lisa Saiman, Bruce C. Marshall et al. JAMA
  4. Predictive 5-Year Survivorship Model of Cystic Fibrosis (2001)
    Theodore G. Liou, Frederick R. Adler et al. American Journal of Epidemiology
  5. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation (2017)
    Philip M. Farrell, Terry B. White et al. The Journal of Pediatrics
  6. Cystic Fibrosis Pulmonary Guidelines (2009)
    Patrick A. Flume, Peter J. Mogayzel et al. American Journal of Respiratory and Critical Care Medicine
  7. Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes (2010)
    Antoinette Moran, Carol Brunzell et al. Diabetes Care
  8. Cystic Fibrosis Pulmonary Guidelines (2013)
    Peter J. Mogayzel, Edward T. Naureckas et al. American Journal of Respiratory and Critical Care Medicine
  9. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary (2015)
    R. Andrés Floto, Kenneth N. Olivier et al. Thorax
  10. The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry (2016)
    Emily A. Knapp, Aliza K. Fink et al. Annals of the American Thoracic Society
  11. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis (2015)
    R. Andrés Floto, Kenneth N. Olivier et al. Thorax

Immediate Impact

5 by Nobel laureates 11 from Science/Nature 100 standout
Sub-graph 1 of 14

Citing Papers

Future therapies for cystic fibrosis
2023 Standout
Cystic Fibrosis
2023 Standout
223 intermediate papers

Works of Bruce C. Marshall being referenced

Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection
2014
Cystic Fibrosis Pulmonary Guidelines
2009 Standout
and 60 more

Author Peers

Author Last Decade Papers Cites
Bruce C. Marshall 9720 2448 1248 1482 136 12.9k
Frank J. Accurso 9616 1719 982 1967 182 12.2k
Christopher H. Goss 7399 2172 963 987 229 10.0k
Michael W. Konstan 14858 2138 721 2459 234 17.5k
Patrick A. Flume 7568 1599 776 1025 228 9.2k
Mary Corey 8588 1489 1735 1109 156 11.5k
Isabelle Sermet‐Gaudelus 6465 1798 620 1578 247 9.7k
Félix Ratjen 14440 2186 1249 2424 409 17.5k
Diana Bilton 5964 1832 732 681 187 7.9k
Jane C. Davies 8706 1319 660 2752 332 12.3k
Eitan Kerem 6959 1339 1151 1734 252 9.7k

All Works

Loading papers...

Rankless by CCL
2026